FindTrial
Sign In

To study and compare the number of pimples reduced after giving Tazarotene gel and Adapalene gel over face in Acne patients

A comparative study of efficacy of 0.05% Tazarotene gel against 0.1% Adapalene gel in patients of facial Acne Vulgaris

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/01/017011
Enrollment
66
Registered
2019-01-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

Intervention1: Tazarotene 0.05% gel: It is applied daily night for 2 months in patients of acne and patient is asked to follow up every 15 days for 3 months Control Intervention1: Adapalene 0.1% gel:

Sponsors

Dr Sanmitra Aiholli
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Facial acne vulgaris of mild to moderate severity. 2 Patients willing to undergo treatment and come for follow up.

Exclusion criteria

Exclusion criteria: 1 Facial acne vulgaris of severe type 2 Pregnant women & women who are planning to conceive.

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of 0.05% Tazarotene gel versus 0.1% Adapalene gel in the treatment of facial acne vulgaris.Timepoint: Patient will be asked to follow up regularly every 2 weeks to 3months—

Secondary

MeasureTime frame
To look for adverse effects of Adapalene 0.05% gel and 0.1% gelTimepoint: every 15 days for 3 months—

Countries

India

Contacts

Public ContactDr Sanmitra Aiholli

Mahatma Gandhi Missions Medical College and Hospital

ashish7557@gmail.com9422213292

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026